Phytosterols decrease prostaglandin release in cultured P388D 1/MAB macrophages

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 70, Issue 6, 2004, Pages 511-520

  Awad, Atif B ^a   Toczek, Jeffrey ^a   Fink, Carol S ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Atherosclerosis; Campesterol; Cholesterol; PGE2; PGI2; Sitosterol

Indexed keywords

CAMPESTEROL; CHOLESTEROL; CYCLODEXTRIN; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; PHYTOSTEROL; PROSTACYCLIN; PROSTAGLANDIN; PROSTAGLANDIN E2; SITOSTEROL;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENZYME ACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION;

EID: 2442422085     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.11.005     Document Type: Article

References (36)

1. American Heart Association, 2001 Heart and Stroke Statistical Update, National Center, AHA Publication, Dallas, TX, 2000, pp. 1-32.
2. R. Ross, The pathogenesis of atherosclerosis: a perspective for the 1990's, Nature 362 (1993) 801-809.
3. A. Kadar, T. Glasz, Development of atherosclerosis and plaque biology, Cardiovasc. Surg. 9 (2001) 109-121.
4. W.B. Kannel, W.P. Castelli, T. Gordon, P.M. McNamara, Serum cholesterol, lipoproteins and the risk of coronary heart disease, Ann. Intern. Med. 74 (1971) 1-12.
5. Z. Chen, R. Peto, R. Collins, A. MacMahon, J. Lu, W. Li, Serum cholesterol concentrations and coronary heart disease in a population with low cholesterol concentrations, BMJ 251 (1984) 365-374.
6. D. Hajjar, A. Nicholson, Atherosclerosis; an understanding of the cellular and molecular basis of the disease promises new approaches for its treatment in the near future, Am. Sci. 83 (1995) 460-467.
7. M.H. Moghadasian, J. Frohlich, Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis: clinical and experimental evidence, Am. J. Med. 107 (1999) 588-594.
8. F.Y. Ntanios, P.J.H. Jones, Dietary sitostanol reciprocally influences cholesterol absorption and biosynthesis in hamsters and rabbits, Atherosclerosis 143 (1999) 341-351.
9. T.A. Miettinen, P. Puska, H. Gylling, H. Vanhanen, E. Vartiainen, Reduction of serum cholesterol with sitostanol-ester margarine in a midly hypercholesterolemic population, N. Engl. J. Med. 3 (1995) 1308-1312.
10. T. Heinemann, G. Aztmann, K. Von Bergmann, Comparison of intestinal absorption of cholesterol with different plant sterols in man, Eur. J. Clin. Invest. 23 (1993) 827-831.
11. H. Gylling, T.A. Miettinen, Cholesterol reduction by different plant stanol mixtures and with variable fat intake, Metabolism 48 (1999) 575-580.
12. J.A. Weststrate, G.W. Meijer, Plant sterol-enriched margarines and reduction of plasma total- and LCL-cholesterol concentrations in normocholesterolemic and mildly hypercholesterolemic subjects, Eur. J. Clin. Nutr. 52 (1998) 334-343.
13. W.H. Ling, P.J.H. Jones, Dietary phytosterols; a review of metabolism, benefits and side effects, Life Sci. 57 (3) (1995) 195-206.
14. A.B. Awad, C.S. Fink, Phytosterols as anticancer dietary components: evidence and mechanism of action, J. Nutr. 130 (2000) 2127-2130.
15. R.M. Berne, M.N. Levy, B.M. Koeppen, B.A. Stanton, Physiology,, Mosby Inc., Missouri, 1998.
16. A.B. Awad, A.J. Smith, C.S. Fink, Plant sterols regulate rat vascular smooth muscle cell growth and prostatacyclin release in culture, Prostagland. Leukotr. Essent. Fatty Acids 64 (2001) 323-330.
17. S. Moncada, Prostacyclin and arterial wall biology, Arteriosclerosis 2 (1982) 193-207.
18. D.U. Silverthorn, W.C. Ober, C.W. Garrision, A.C. Silverthorn, Human Physiology: an Integrated Approach, Prentice-Hall, NJ, 1998, pp. 80-300.
19. 1 macrophage-like cells, Ann. NY Acad. Sci. 744 (1994) 1-10.
20. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
21. A.B. Awad, M.D. Garcia, C.S. Fink, Effect of dietary phytosterols on rat tissue lipids, Nutr. Cancer 29 (1997) 212-216.
22. S.N. Mathur, E. Albright, F.J. Field, Decreased prostaglandin production by cholesterol-rich macrophages, J. Lipid Res. 30 (1999) 287-293.
23. S. Moncada, J.R. Vane, Arachidonic acid metabolites and the interactions between platelets and blood-vessels walls, J. Med. 300 (1979) 1142-1147.
24. 2s, J. Biol. Chem. 274 (1999) 12263-12268.
25. A.W. Ford-Hutchinson, M.V. Doig, Prostaglandins and macrophages, Agents Actions 6 (Suppl.) (1979) 151-155.
26. 2 production: correlation with changes in human aortic atherosclerotic disease, Arteriosclerosis 4 (1984) 70-78.
27. R.L. Jones, R.A. Armstrong, H. Wise, Prostaglandin receptors involved in inflammatory events, Adv. Exp. Med. Biol. 400A (1997) 241-245.
28. 1 biosynthesis and effect in pigeon aorta; possible role in atherogenesis, Atherosclerosis 28 (1978) 487-495.
29. D. Fitzgerald, L. Roy, G. Fitzgerald, Enhanced prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation, N. Engl. J. Med. 310 (1984) 1065-1068.
30. G.G. Serneri, G. Masotti, L. Poggesi, G. Galanti, A. Morettini, L. Scarti, Reduced prostacyclin production in patients with different manifestations of ischemic heart disease, Am. J. Cardiol. 49 (1982) 1146-1151.
31. K.B. Pomerantz, D.P. Hajjar, Eicosanoid metabolism in cholesterol-enriched arterial smooth muscle cells: reduced arachidonate release with concomitant decrease in cyclooxygenase products, J. Lipid Res. 30 (1989) 1219-1231.
32. 2-dependent induction of cyclooxygenase-2 in macrophages, J. Biol. Chem. 274 (1999) 25967-25970.
33. A.B. Awad, A.C. Downie, C.S. Fink, U. Kim, Dietary phytosterols inhibit the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice, Anticancer Res. 20 (2000) 821-824.
34. R.L. von Holtz, C.S. Fink, A.B. Awad, β-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells, Nutr. Cancer 32 (1998) 8-12.
35. A.B. Awad, R.L. von Holtz, J. Cone, C.S. Fink, Y.-C. Chen, β-Sitosterol inhibits the growth of HT-29 human colon cancer cells by activating the sphingomyelin cycle, Anticancer Res. 18 (1997) 471-479.
36. A. Ness, J. Powles, Fruit and vegetables and cardiovascular disease: a review, Int. J. Epidemiol. 26 (1) (1997) 1-13.